Houston, Texas
In this issue of JACC: Cardiovascular Imaging, Detaint et al. (1) report that accurate quantification of the amount of aortic regurgitation (AR) present in a given patient and the effect of that amount of AR on left ventricular (LV) function (indicated by end systolic volume index) are prognostic of outcome. Furthermore, these measures were superior to qualitative measures of AR-such as AR grade, jet-width, and so forth-in predicting outcome. Their findings make absolute sense, are not surprising, and are totally consistent with previous findings from Enriquez-Sarano et al. (2) regarding mitral regurgitation. You see, this is a group of cardiologists, folks who study the function of the heart by measuring what it does. What is surprising is that some will find their findings surprising. Those surprised are the same people, by the way, who, when asked for an opinion about how much AR a patient has, say, "Well I think it's about 2 to 3ϩ." What in the world does that mean?
See page 1 Accurate calculation of cardiac volumes with contrast angiography has been available since the 1960s and was refined to an art form by the 1970s, allowing very accurate calculation of regurgitant volumes (2) (3) (4) (5) (6) . Indeed such quantification of AR was reported superior to qualitative measures almost 25 years ago (7) . I recognize that nothing could be more pointless than to yearn for the good old days when cardiologists knew these techniques or could measure a transvalvular gradient accurately in the catheterization laboratory or knew the limitations of valve area and did not report those areas out to 2 decimal places. But when catheterization laboratories became interventional venues and diagnosis moved to noninvasive laboratories, why did we have to start all over again? Why did it take 25 years to get back to where we were in the invasive era of cardiac diagnosis? To be sure, a whole new diagnostic tool with its clear noninvasive advantage had to be developed, and initially the images available did not lend themselves well to precise quantification. And it was not really until Doppler interrogation arrived that a primarily anatomic technique became empowered to reveal physiology. Still, as a group we seem to avoid quantification and embrace qualitation, even when more sophisticated technology exists.
It is not just in the determination of cardiac volumes that we have fallen down; it seems our ambivalence toward quantification occurs in many other areas of cardiology. Undeniably the most important function of the myocardium is to generate force by which it contracts against a load, propelling blood forward to sustain life. The innate force-generating capacity of the heart, contractility is widely thought to be key to prognosis in heart disease (8) . At least 30 indexes have been developed to measure this function, yet ejection fraction, with all its foibles and load dependence, is used ubiquitously to assess cardiac performance, even in valvular heart disease where load is pointedly altered. It was refreshing to see end-systolic volume reaffirmed here as a useful prognostic index in AR (1,9,10). End-systolic volume and/or dimension are dependent upon contractility, afterload, and sarcomere number but are independent of preload. Thus, at least one of the factors confounding ejection fraction is removed when this index is used. Admittedly, many other indexes of LV function are cumbersome to use and difficult to understand, and ejection fraction "works" in many instances. Yet limitations of ejection fraction as a useful tool are often ignored, leading in some cases to poor clinical judgment. How often I have heard that an ejection fraction of 0.55 in a patient with mitral regurgitation indicates normal LV function or that the patient with aortic stenosis and a reduced ejection fraction has LV dysfunction when at the myocardial level neither might be true.
Then there is assessment of coronary stenoses. For decades we have known that 2 highly trained angiographers "eyeballing" the same coronary stenosis might have two very different interpretations of the same lesion or, when seeing the same lesion again at a different time, might assess a different degree of stenosis than when it was examined the first time (11) (12) (13) . In recognition of this weakness, a large investment was made in developing quantitative angiography, Doppler-and pressure-assessed (fractional) flow reserve, and intravascular ultrasound (14 -17) . Yet, as noted in the most recent edition of a popular textbook, "In clinical practice, however, the degree of lesion stenosis is usually just estimated visually from the coronary angiogram" (18) . Indeed, in my experience, this statement is accurate for most catheterization laboratories.
Why do we behave like this? Is it because we are too busy to measure things accurately? Is it because we do not understand the principles behind quantification? Is it because simpler methods work fairly well most of the time? I suspect it is a little of all of these components that form our practice. To be sure, there are many times when the severity of a lesion is so great or so trivial that quantification is unnecessary. Yet we would rarely accept qualitation in other parts of medicine. Would it be acceptable for our nephrologist to tell us that our patient's potassium was moderately elevated or for our hematologist to tell us that our patient's international normalized ratio was moderately out of range? I doubt it.
Perhaps we are entering a new era when our patients demand more precision from us and we will demand more from ourselves. An era when cardiac imaging is so sophisticated that it will yield accurate cardiac measurements more easily. The data presented by Detaint et al. (1) indicate that such precision has real impact on our ability to better gauge prognosis and find the proper timing of surgery. I personally hope their study spurs us to do better not only in valvular heart disease but also in other areas of our profession. However, for this to happen we and our trainees must recognize that, from the time Werner Forssmann placed a catheter in his own antecubital vein and Richards and Cournand used that principle to make intracardiac measurements leading to the Nobel Prize (19, 20) , part of cardiology is physiology: to understand the heart we must understand how it works, and to understand when it is not working we must be able to measure aspects of its function accurately. If we can remember that we are all physiologists and remember to act like physiologists, perhaps statements like "Well, I think he's got 2 to 3 ϩ AR" will disappear, resulting in better care for our patients. Let's hope that modern cardiac imaging reconnects us with a basic foundation of cardiology that is, in fact, physiology. 
